Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results.
about
Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsXpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adultsRapid antibiotic-resistance predictions from genome sequence data for Staphylococcus aureus and Mycobacterium tuberculosisPredicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutationsMultidrug-resistant tuberculosis drug susceptibility and molecular diagnostic testingThe rationale for using rifabutin in the treatment of MDR and XDR tuberculosis outbreaksMulti drug resistant tuberculosis in Mosango, a rural area in the Democratic Republic of CongoFirst evaluation of drug-resistant Mycobacterium tuberculosis clinical isolates from Congo revealed misdetection of fluoroquinolone resistance by line probe assay due to a double substitution T80A-A90G in GyrACorrelation between genotypic and phenotypic testing for resistance to rifampin in Mycobacterium tuberculosis clinical isolates in Haiti: investigation of cases with discrepant susceptibility resultsQuantitative drug-susceptibility in patients treated for multidrug-resistant tuberculosis in Bangladesh: implications for regimen choice.Whole Genome Sequencing Investigation of a Tuberculosis Outbreak in Port-au-Prince, Haiti Caused by a Strain with a "Low-Level" rpoB Mutation L511P - Insights into a Mechanism of Resistance EscalationDiscordance across Phenotypic and Molecular Methods for Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates in a Low TB Incidence CountryDiagnostic Molecular Mycobacteriology in Regions With Low Tuberculosis Endemicity: Combining Real-time PCR Assays for Detection of Multiple Mycobacterial Pathogens With Line Probe Assays for Identification of Resistance MutationsPerformance of tuberculosis drug susceptibility testing in U.S. laboratories from 1994 to 2008Integrated microfluidic card with TaqMan probes and high-resolution melt analysis to detect tuberculosis drug resistance mutations across 10 genes.Concordance between molecular and phenotypic testing of Mycobacterium tuberculosis complex isolates for resistance to rifampin and isoniazid in the United StatesDetection of tuberculosis drug resistance: a comparison by Mycobacterium tuberculosis MLPA assay versus Genotype®MTBDRplus.Mixed Mycobacterium tuberculosis complex infections and false-negative results for rifampin resistance by GeneXpert MTB/RIF are associated with poor clinical outcomes.Comparison of different drug susceptibility test methods to detect rifampin heteroresistance in Mycobacterium tuberculosis.Effects of introducing Xpert MTB/RIF test on multi-drug resistant tuberculosis diagnosis in KwaZulu-Natal South Africa.Assessment of the genotype MTBDRplus assay for rifampin and isoniazid resistance detection on sputum samples in Cote d'Ivoire.Evaluation of tuberculosis diagnostics: establishing an evidence base around the public health impact.Sequence analysis for detection of first-line drug resistance in Mycobacterium tuberculosis strains from a high-incidence settingDrug resistance-conferring mutations in Mycobacterium tuberculosis from Madang, Papua New Guinea.Diagnostic value of GeneChip for detection of resistant Mycobacterium tuberculosis in patients with differing treatment historiesEvaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countriesMolecular detection of mutations associated with first- and second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis.Laboratory diagnosis of tuberculosis in resource-poor countries: challenges and opportunitiesDiscordance between Xpert MTB/RIF assay and Bactec MGIT 960 Culture System for detection of rifampin-resistant Mycobacterium tuberculosis isolates in a country with a low tuberculosis (TB) incidence.Pyrosequencing for rapid molecular detection of rifampin and isoniazid resistance in Mycobacterium tuberculosis strains and clinical specimensDried culture spots for Xpert MTB/RIF external quality assessment: results of a phase 1 pilot study in South Africa.First evaluation of an improved assay for molecular genetic detection of tuberculosis as well as rifampin and isoniazid resistancesGenotypic, Phenotypic and Clinical Validation of GeneXpert in Extra-Pulmonary and Pulmonary Tuberculosis in India.Comparison of Three Commercial Molecular Assays for Detection of Rifampin and Isoniazid Resistance among Mycobacterium tuberculosis Isolates in a High-HIV-Prevalence SettingDelamanid susceptibility testing of Mycobacterium tuberculosis using the resazurin microtitre assay and the BACTEC™ MGIT™ 960 system.Rapid diagnosis of tuberculosis and multidrug resistance using a MGIT 960 systemRapid, high-throughput detection of rifampin resistance and heteroresistance in Mycobacterium tuberculosis by use of sloppy molecular beacon melting temperature codingPredicting differential rifamycin resistance in clinical Mycobacterium tuberculosis isolates by specific rpoB mutations.Performance of the G4 Xpert® MTB/RIF assay for the detection of Mycobacterium tuberculosis and rifampin resistance: a retrospective case-control study of analytical and clinical samples from high- and low-tuberculosis prevalence settingsComparative accuracy of the REBA MTB MDR and Hain MTBDRplus line probe assays for the detection of multidrug-resistant tuberculosis: A multicenter, non-inferiority study
P2860
Q24200879-BFE1DFCA-2A94-44C6-8E0C-3FA455D8763BQ24201466-5E3626F9-1235-4B02-A08A-08D6A65ECA13Q27342229-4B2F1559-BD54-40B8-BFAF-6ECA0CCE0D96Q28397752-19F945FD-5609-4774-B55D-42B86A1E31EBQ28485230-6902016E-2B93-4976-AD4B-15A89316A4BBQ28488204-99661CCD-D393-4C2F-8000-610C279D15F3Q28537853-D9F4EAAD-7518-4A0B-BC0D-B4670FFA37F9Q28538008-1B13DE49-D87E-4670-9246-F6B2306F3DDCQ28540488-965A25CF-222B-463A-979E-C4792A51B517Q28543642-BDDBFD56-B277-49B8-9113-8DFDFBC40B25Q28547769-A79233C3-390E-4326-BB7B-2C145091D39CQ28551469-77554351-C43F-48BA-A86F-990841B5089CQ28831411-ADFADAAD-37BC-4C35-8C6C-E8A3DC55FAA2Q30224757-FA99298D-4881-423A-BABE-8113C2568E31Q30300560-2CB8420B-8F70-47A9-844C-EF943B5B62C1Q33703407-BFACBAB2-49E9-465E-8AC9-0A03808E2C7EQ33732298-DB91B4DB-A148-4923-8640-9D210BBC4953Q33900005-6438222C-A38D-4AA7-8178-9D89A48BDB60Q34057296-7E6281BE-D400-41ED-9E9F-6356182141FCQ34076574-73747CA0-63E3-417C-AAE7-00DEBE5B7233Q34162862-5C2E8BB3-63F0-4F49-98F7-C146060D32A5Q34224000-23D2150B-8D68-40DB-B816-E841B84B3F16Q34286080-5D5EE812-BCCB-4146-B304-2088375D3F6BQ34401993-9587B383-E036-484F-9E74-3A67FE7FE900Q34916301-E78DD822-350A-4848-8591-45783D72D2D5Q34922635-8A1F2842-0528-4632-94F7-71DCB23BBFC1Q34933405-09486D34-BC76-4C1C-A906-D6E8BFAC349CQ35066020-AC0D4B77-7137-4A5D-8621-DD00395C310EQ35193175-B5BEEAD5-17E9-4D7A-A525-A06F14B892A8Q35273474-EA669429-E49E-4830-86F8-53BA1F0C40FCQ35598939-C945A348-C4C1-438E-951D-5C4AB4F0947CQ35867811-FAAB81E4-E0A8-4FEC-8EAB-110BB05A91B7Q35928273-671DF304-2352-4239-B9A2-500C090C54B7Q35968590-FEEA69BF-BB8B-489C-9001-A017EEE1F97AQ35989196-F7383A3B-C5A3-485C-B8A0-9171D6274FDDQ36063148-0319852B-DDCB-457C-B64D-3E1C207210FEQ36118693-F209DE08-78A0-4249-A6AB-769D213E6404Q36169719-E6C5196F-122B-4372-9CB3-9D0F27020DDDQ36228816-505AA0D4-9D1A-43CD-8495-A28273BDF8EBQ36322028-929BF983-6CA9-4945-9B1A-A50649782F47
P2860
Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 16 September 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Mycobacterium tuberculosis str ...... n susceptibility test results.
@en
Mycobacterium tuberculosis str ...... n susceptibility test results.
@nl
type
label
Mycobacterium tuberculosis str ...... n susceptibility test results.
@en
Mycobacterium tuberculosis str ...... n susceptibility test results.
@nl
prefLabel
Mycobacterium tuberculosis str ...... n susceptibility test results.
@en
Mycobacterium tuberculosis str ...... n susceptibility test results.
@nl
P2093
P2860
P356
P1476
Mycobacterium tuberculosis str ...... in susceptibility test results
@en
P2093
A Van Deun
H Hoffmann
S Rüsch-Gerdes
P2860
P304
P356
10.1128/JCM.01209-09
P407
P577
2009-09-16T00:00:00Z